MeMed Diagnostics
Diagnostic Tools for Infectious Diseases
StartupMeMed Diagnostics is a Tirat Carmel-based startup in the Health Tech & Life Sciences sector, established in 2009. Diagnostic Tools for Infectious Diseases. The company has raised a total of $223.43M across 11 funding rounds, currently at the E stage. MeMed Diagnostics was founded by Kfir Oved and Eran Eden. Key investors include La Maison Partners, OurCrowd, Phoenix Insurance, among 11 total investors. The company has 51-200 employees. Core technologies: Artificial Intelligence, Machine Learning.
With $223.43M in total funding, MeMed Diagnostics is a E-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Released. The company holds 1 patent.
- StageE
- ProductReleased
- ModelB2B
- Employees51-200
- HQTirat Carmel
- DistrictNorth District
- Last Round$93M
- La Maison Partners
- OurCrowd
- Phoenix Insurance
11 investors total
Kfir OvedCo-founder, CTO & Chairman
Eran EdenCo-founder & CEO
28 articles covered by sources including www.investegate.co.uk,
www.calcalistech.com,
nocamels.com,
www.globes.co.il,
www.globenewswire.com.
What does MeMed Diagnostics do?
MeMed Diagnostics has developed and validated an immune-based protein signature, MeMed BV, which distinguishes between bacterial and viral infections, providing a powerful tool in the fight against resistant strains of bacteria. An ELISA format of MeMed BV called ImmunoXpert is cleared for use in the EU (CE-IVD), Switzerland, and Israel and is currently in pilot distribution in these areas. MeMed is also developing MeMed Key, a platform that paves the way for measuring multiple proteins and signatures, both conventional and innovative, with central lab precision at the point of care. MeMed Key will measure MeMed BV within minutes. In September 2021, the company was granted 510(k) clearance by the FDA for MeMed BV for adults and children.
How much funding has MeMed Diagnostics raised?
MeMed Diagnostics has raised $223.43M in total funding across 11 rounds. The company is currently at the E stage. Key investors include La Maison Partners, OurCrowd, Phoenix Insurance.
Who founded MeMed Diagnostics?
MeMed Diagnostics was founded in 2009 by Kfir Oved (Co-founder, CTO & Chairman), Eran Eden (Co-founder & CEO).
What sector is MeMed Diagnostics in?
MeMed Diagnostics operates in Health Tech & Life Sciences, Digital Healthcare, Digital Medical Diagnostics, Medical Decision Support, Medical Devices, Diagnostics Devices, with core technologies in Artificial Intelligence, Machine Learning. Target customers: Healthcare & Life Sciences, Healthcare, Laboratories, Providers.
Where is MeMed Diagnostics located?
MeMed Diagnostics is based in Nahum Het St 5, Tirat Carmel, Israel, North District.